1555 related articles for article (PubMed ID: 27108416)
21. Comparison of clinical features in patients with eosinophilic esophagitis living in an urban and rural environment.
Lee YJ; Redd M; Bayman L; Frederickson N; Valestin J; Schey R
Dis Esophagus; 2015 Jan; 28(1):19-24. PubMed ID: 24382218
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences.
Eluri S; Dellon ES
Curr Opin Gastroenterol; 2015 Jul; 31(4):309-15. PubMed ID: 26039722
[TBL] [Abstract][Full Text] [Related]
23. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia.
Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Quevedo S; Bracamonte T; Román E
J Pediatr Gastroenterol Nutr; 2016 May; 62(5):704-10. PubMed ID: 26513622
[TBL] [Abstract][Full Text] [Related]
24. Esophageal Eosinophilia Is Common Among Relatives of Eosinophilic Esophagitis Patients.
Peterson K; Clayton F; Qeadan F; Gorman D; Robson J; Allen-Brady K; Fang JC
Clin Gastroenterol Hepatol; 2022 May; 20(5):e957-e963. PubMed ID: 33221551
[TBL] [Abstract][Full Text] [Related]
25. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
[TBL] [Abstract][Full Text] [Related]
26. Eosinophilic esophagitis in Japanese patients: A mild and slow-progressing disorder.
Sato H; Honma T; Nozawa Y; Owaki T; Imai M; Sano T; Iwanaga A; Seki K; Ishikawa T; Yoshida T; Terai S
PLoS One; 2018; 13(11):e0206621. PubMed ID: 30388148
[TBL] [Abstract][Full Text] [Related]
27. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression.
Molina-Infante J; Rivas MD; Hernandez-Alonso M; Vinagre-Rodríguez G; Mateos-Rodríguez JM; Dueñas-Sadornil C; Perez-Gallardo B; Ferrando-Lamana L; Fernandez-Gonzalez N; Bañares R; Zamorano J
Aliment Pharmacol Ther; 2014 Oct; 40(8):955-65. PubMed ID: 25112708
[TBL] [Abstract][Full Text] [Related]
28. Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia.
Iwakura N; Fujiwara Y; Tanaka F; Tanigawa T; Yamagami H; Shiba M; Tominaga K; Watanabe T; Iijima K; Koike T; Walls AF; Arakawa T
Aliment Pharmacol Ther; 2015 Apr; 41(8):776-84. PubMed ID: 25693747
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic findings in patients with Schatzki rings: evidence for an association with eosinophilic esophagitis.
Müller M; Eckardt AJ; Fisseler-Eckhoff A; Haas S; Gockel I; Wehrmann T
World J Gastroenterol; 2012 Dec; 18(47):6960-6. PubMed ID: 23322994
[TBL] [Abstract][Full Text] [Related]
30. Proton pump inhibitor responsive esophageal eosinophilia, a distinct disease entity?
Munday W; Zhang X
World J Gastroenterol; 2014 Aug; 20(30):10419-24. PubMed ID: 25132757
[TBL] [Abstract][Full Text] [Related]
31. Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009.
Kidambi T; Toto E; Ho N; Taft T; Hirano I
World J Gastroenterol; 2012 Aug; 18(32):4335-41. PubMed ID: 22969196
[TBL] [Abstract][Full Text] [Related]
32. Esophageal Food Impaction and Eosinophilic Esophagitis: A Retrospective Study, Systematic Review, and Meta-Analysis.
Hiremath GS; Hameed F; Pacheco A; Olive A; Davis CM; Shulman RJ
Dig Dis Sci; 2015 Nov; 60(11):3181-93. PubMed ID: 26065368
[TBL] [Abstract][Full Text] [Related]
33. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis.
Molina-Infante J; Katzka DA; Gisbert JP
Aliment Pharmacol Ther; 2013 Jun; 37(12):1157-64. PubMed ID: 23656497
[TBL] [Abstract][Full Text] [Related]
34. Allergic phenotype identified on allergen testing is associated with proton pump inhibitor nonresponse in eosinophilic esophagitis.
Muftah M; Hartnett DA; Flanagan R; Redd WD; Jenkins A; Goldin AH; Hsu Blatman K; Chan WW
J Gastroenterol Hepatol; 2024 Apr; 39(4):701-707. PubMed ID: 38185799
[TBL] [Abstract][Full Text] [Related]
35. Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis.
Molina-Infante J; van Rhijn BD
Best Pract Res Clin Gastroenterol; 2015 Oct; 29(5):749-758. PubMed ID: 26552774
[TBL] [Abstract][Full Text] [Related]
36. Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders.
Hait EJ; McDonald DR
Clin Rev Allergy Immunol; 2019 Oct; 57(2):213-225. PubMed ID: 30206783
[TBL] [Abstract][Full Text] [Related]
37. A Single-center Experience of Esophageal Eosinophilia.
Cho KW; Huh CW; Jung DH; Youn YH; Park H
Korean J Gastroenterol; 2018 Jul; 72(1):10-14. PubMed ID: 30049172
[TBL] [Abstract][Full Text] [Related]
38. Effect of proton pump inhibitor on esophageal eosinophilia.
Schroeder S; Capocelli KE; Masterson JC; Harris R; Protheroe C; Lee JJ; Furuta GT
J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):166-72. PubMed ID: 23325438
[TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis.
Molina-Infante J; Bredenoord AJ; Cheng E; Dellon ES; Furuta GT; Gupta SK; Hirano I; Katzka DA; Moawad FJ; Rothenberg ME; Schoepfer A; Spechler SJ; Wen T; Straumann A; Lucendo AJ;
Gut; 2016 Mar; 65(3):524-31. PubMed ID: 26685124
[TBL] [Abstract][Full Text] [Related]
40. CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis.
Mougey EB; Williams A; Coyne AJK; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Román E; González Lois C; Chao M; Al-Atrash H; Lima JJ; Franciosi JP
J Pediatr Gastroenterol Nutr; 2019 Nov; 69(5):581-587. PubMed ID: 31490856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
